Flow cytometry market was valued at $10.2 billion in 2025 and is projected to reach $21.7 billion by 2035, growing at a CAGR of 7.9% during the forecast period (2026-2035).  The rapid expansion of diagnostic laboratories globally is emerging as a key growth driver for the global flow cytometry Market. As the number of laboratories increases, the overall testing capacity for clinical diagnostics has significantly expanded, particularly in areas such as cancer screening, hematology testing, immunodeficiency disorders, and infectious disease diagnostics. This growing diagnostic infrastructure is enabling higher volumes of routine blood and cell-based analyses, where flow cytometry plays a critical role due to its ability to deliver fast, accurate, and multi-parameter cellular characterization. 

Eye cancer market was valued at $16.2 billion in 2025 and is projected to reach $35.7 billion by 2035, growing at a CAGR of 8.3% during the forecast period (2026-2035). The incidence of eye cancer, although relatively low compared to other oncology indications, is showing a gradual increase across several regions, thereby contributing to market expansion. In the United States, the American Cancer Society estimates approximately 3,200 new cases of primary eye and orbit cancers in 2026, along with around 530 associated mortality, indicating a steady disease burden. Similarly, in the United Kingdom, nearly 850 cases are diagnosed annually, reinforcing the presence of a consistent patient pool in developed markets. While primary eye cancers remain rare, the growing identification of both primary and secondary ocular malignancies is improving overall case detection rates. Emerging economies such as India also contribute significantly to global incidence, with nearly 1,000 cases reported, a large proportion of which occur in children, particularly in the 0–4 age group due to conditions such as retinoblastoma. 

Eubiotics market was valued at $6.5 billion in 2025 and is projected to reach $14.6 billion by 2035, growing at a CAGR of 8.6% during the forecast period (2026-2035). The sustained increase in livestock production volumes is a primary structural factor supporting demand for eubiotics in animal nutrition. According to the Food and Agriculture Organization, global meat production reached approximately 374 million tonnes in 2024, reflecting continued growth in animal protein output driven by rising consumption patterns and population dynamics. Poultry alone accounts for nearly 40% of total meat production, highlighting its dominance within intensive farming systems where feed efficiency and gut health are critical performance parameters. 

DNS service market was valued at $1.4 billion in 2025 and is projected to reach $4.4 billion by 2035, growing at a CAGR of 12.3% during the forecast period (2026-2035). As businesses increasingly embrace cloud infrastructures and edge technologies to efficiently process growing volumes of data, the demand for secure, resilient, and high-performance digital environments has become critical. This trend has accelerated the adoption of cloud-based DNS services, as organizations look scalable, globally distributed, and managed solutions over traditional on-premises infrastructure. Cloud DNS not only reduces latency and enhances redundancy for users globally but also strengthens operational continuity amid rising cyber security threats. Government initiatives are actively supporting the transition to secure and resilient cloud and edge infrastructures, providing frameworks and funding to enhance digital operations.

Cyber Security market was valued at $128.2 billion in 2025 and is projected to reach $339.0 billion by 2035, growing at a CAGR of 10.3% during the forecast period (2026-2035). The increasing frequency of cybercrime continues to drive expansion in the global cybersecurity market, as organizations face escalating exposure to digital threats. Rapid digital transformation across industries has led to a substantial rise in sensitive data volumes, interconnected devices, and online operations, significantly broadening the potential attack surface. In response, organizations are investing in comprehensive cybersecurity solutions, including endpoint protection, network security, cloud security, and identity management, to strengthen defenses, enable faster incident response, and reduce operational risk. 

Color coated steel market was valued at $26.9 billion in 2025 and is projected to reach $43.9 billion by 2035, growing at a CAGR of 5.1% during the forecast period (2026-2035). The growth of the global color coated steel market is strongly driven by the rapid expansion of the construction and infrastructure sector globally. Increasing demand for roofing, cladding, and pre-engineered buildings (PEBs) has significantly accelerated the adoption of color coated steel due to its durability, corrosion resistance, and aesthetic appeal. The ongoing wave of urbanization and large-scale smart city developments in countries such as India and China is further fueling demand for advanced construction materials, including pre-painted steel products. Additionally, color coated steel is extensively utilized in the development of industrial sheds, logistics warehouses, airports, and metro infrastructure projects, where speed of construction and long-term performance are critical. 

Colonoscopy devices market was valued at $2.8 billion in 2025 and is projected to reach $4.7 billion by 2035, growing at a CAGR of 5.3% during the forecast period (2026-2035). The integration of artificial intelligence (AI) into colonoscopy devices represents one of the most significant advancements in the global market, fundamentally transforming diagnostic accuracy and procedural efficiency. AI-assisted colonoscopy, particularly through Computer-Aided Detection (CADe) and Computer-Aided Diagnosis (CADx), enables real-time identification and characterization of colorectal polyps during procedures. These systems leverage deep learning algorithms to enhance visualization, allowing clinicians to detect subtle lesions that may otherwise be missed with conventional techniques.

Cloud-based product lifecycle management market was valued at $26.5 billion in 2025 and is projected to reach $89.5 billion by 2035, growing at a CAGR of 8.3% during the forecast period (2026-2035).  The global cloud-based Product Lifecycle Management (PLM) market is witnessing significant growth, driven by the increasing deployment of Generative AI across all stages of the product lifecycle. Generative AI technologies are addressing critical industry challenges such as design errors and prolonged development cycles by enabling automated generation of CAD models and intelligent design recommendations. Companies such as Siemens have integrated Generative AI into their PLM solutions, allowing engineers to optimize product designs and substantially reduce engineering time. By leveraging vast volumes of product data stored within cloud-based PLM systems, AI empowers organizations to enhance decision-making and streamline product development processes. 

Clinical decision support system market was valued at $5.9 billion in 2025 and is projected to reach $13.0 billion by 2035, growing at a CAGR of 8.3% during the forecast period (2026-2035). Government investment in digital healthcare infrastructure has become a major catalyst for advancing the global Clinical Decision Support System (CDSS) market. In nation such as India, the Ayushman Bharat Digital Mission (ABDM) has achieved remarkable scale, with over 834 million citizens holding Ayushman Bharat Health Accounts (ABHA), approximately 438,000 health facilities registered, and 738,000 healthcare professionals integrated into the digital ecosystem, facilitating seamless interoperability of health records and enhanced clinical data access. Such large-scale digitization enables better utilization of advanced CDSS tools, as clinicians can access longitudinal patient data in real time, leading to improved diagnosis and treatment decisions while reducing errors and operational inefficiencies.

Catheter market was valued at $21.4 billion in 2025 and is projected to reach $41.9 billion by 2035, growing at a CAGR of 7.1% during the forecast period (2026-2035). The global catheters market is witnessing steady growth, driven by the increasing prevalence of kidney-related disorders and the rising need for effective clinical management solutions. Catheters are widely utilized across multiple renal conditions to facilitate urine drainage, enable dialysis procedures, and relieve urinary obstructions. Among these conditions, Chronic Kidney Disease represents a major contributor to market expansion, with approximately 788 million cases reported globally based in 2023, accounting for nearly 14.2% of the adult population. The overall burden of kidney-related disorders, including acute and end-stage conditions, exceeds 850 million cases as per 2024–2025 assessments, reinforcing the growing requirement for catheter-based interventions.